Sialoglycan recognition is a common connection linking acidosis, zinc, and HMGB1 in sepsis
Open Access
- 3 March 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (10)
- https://doi.org/10.1073/pnas.2018090118
Abstract
Blood pH is tightly maintained between 7.35 and 7.45, and acidosis (pH <7.3) indicates poor prognosis in sepsis, wherein lactic acid from anoxic tissues overwhelms the buffering capacity of blood. Poor sepsis prognosis is also associated with low zinc levels and the release of High mobility group box 1 (HMGB1) from activated and/or necrotic cells. HMGB1 added to whole blood at physiological pH did not bind leukocyte receptors, but lowering pH with lactic acid to mimic sepsis conditions allowed binding, implying the presence of natural inhibitor(s) preventing binding at normal pH. Testing micromolar concentrations of divalent cations showed that zinc supported the robust binding of sialylated glycoproteins with HMGB1. Further characterizing HMGB1 as a sialic acid-binding lectin, we found that optimal binding takes place at normal blood pH and is markedly reduced when pH is adjusted with lactic acid to levels found in sepsis. Glycan array studies confirmed the binding of HMGB1 to sialylated glycan sequences typically found on plasma glycoproteins, with binding again being dependent on zinc and normal blood pH. Thus, HMGB1-mediated hyperactivation of innate immunity in sepsis requires acidosis, and micromolar zinc concentrations are protective. We suggest that the potent inflammatory effects of HMGB1 are kept in check via sequestration by plasma sialoglycoproteins at physiological pH and triggered when pH and zinc levels fall in late stages of sepsis. Current clinical trials independently studying zinc supplementation, HMGB1 inhibition, or pH normalization may be more successful if these approaches are combined and perhaps supplemented by infusions of heavily sialylated molecules.Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R01GM32373)
This publication has 84 references indexed in Scilit:
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine releaseThe Journal of Experimental Medicine, 2012
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012
- Sepsis: Something old, something new, and a systems viewJournal of Critical Care, 2012
- Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)Online Journal of Public Health Informatics, 2011
- A Sialylated Glycan Microarray Reveals Novel Interactions of Modified Sialic Acids with Proteins and VirusesOnline Journal of Public Health Informatics, 2011
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine releaseProceedings of the National Academy of Sciences of the United States of America, 2010
- Neutrophil TLR4 expression is reduced in the airways of infants with severe bronchiolitisThorax, 2009
- CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune ResponsesScience, 2009
- Therapeutic potential of HMGB1-targeting agents in sepsisExpert Reviews in Molecular Medicine, 2008
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008